Global report - August 14, 2017
EMA prepares for Brexit
The European Medicines Agency (EMA) has developed and initiated a business continuity plan to deal with the uncertainty and workload implications linked to the United Kingdom’s withdrawal from the European Union and the Agency’s relocation. “Preparing for the move, managing the necessary changes, and addressing challenges such as possible losses in skilled and experienced staff, […]